![Addressing the yearly $53B problem for pharma companies using groundbreaking AI and ‘Patient- on-a-chip’ technology](https://industry.pharmafocusasia.com/slider/1719490827-addressing-the-yearly-01.png)
Ractigen Therapeutics a leader in small activating RNA therapies has received Rare Pediatric Disease Designation from the US Food and Drug Administration for its saRNA candidate RAG
IASO Biotechnology a company specializing in advanced cell therapy and antibody products has received approval from the National Medical Products Administration for its investigational new drug
Aforalls US subsidiary Milla Pharmaceuticals Inc has introduced its generic version of PrecedexDexmedetomidine Hydrochloride Injection in mcg per mL and mcg per mL formulated
Eisai Co Ltd and EcoNaviSta Inc have formed a strategic alliance to tackle dementia a significant challenge in Japans aging population Eisai a leader in dementia research and awareness and EcoNaviSta
Pfizer Inc has released positive topline results from the Phase AFFINE study which tested giroctocogene fitelparvovec a gene therapy for adults with moderately severe to severe hemophilia A
BeiGene Ltd a global oncology company has launched its flagship US facility at the Princeton West Innovation Campus in Hopewell NJ This advanced site features cuttingedge biologics
Macquarie University researchers have identified a gene therapy that could help treat the eye disease glaucoma with potential applications for other neurodegenerative conditions such as Alzheimers disease Glaucoma may result in irreversible blindness over to years if left untreated Like Alzheimers...
BioThera Solutions Inc a commercialstage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars today announced that dosing has recently begun in an integrated Phase I
Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes highquality medicines for the treatment of oncology cardiovascular and metabolic
ObvioHealth a global digital clinical trials company announces a new strategic investment by Guardant Health Inc a leading precision oncology company offering liquid
BioThera Solutions Inc a commercialstage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars today announced that the FDA has accepted the BLA for BAT a proposed
NanoViricides Inc a clinical stage global leader in broadspectrum antiviral nanomedicines today reminds the strong safety and effectiveness against coronaviruses demonstrated by its lead clinical drug candidate
Boston, MA, USA
jakarta barat, Indonesia
Jakarta Barat, Indonesia
Songdo Convensia, Incheon, South Korea
Songdo Convensia, Incheon, South Korea
Lisbon, Portugal
London, UK
Geneticist and Genetic Counselor, MFC Woman and Child Care, West Bengal, India
Assistant Professor, Department of Zoology; Ramakrishna Mission Vivekananda Centenary College, West Bengal, India
Department of Pharmaceutical Science and Technology, Institute of Chemical Technology (ICT)
Department of Pharmaceutical Science and Technology, Institute of Chemical Technology (ICT)
Assistant Professor, IIIT Allahabad
Post-Doctoral Fellow, Department of Applied Sciences, IIIT Allahabad
Ashwini Kumar, Assistant Professor, Biotechnology and Bioinformatics Area, NIIT University.
President
Asia has had a dramatic spike in interest for medical research pharma advancement and global investment China and India are emerging as leaders in clinical trials They recruit patients faster cheaper and are better than Europe South America or the US because the economies are encouraging more researchNSF remediation experts work to assist companies around the world in their remediation efforts Some projects arise from a client identifying a risk themselves while others are a company responding to a communication from a regulatory agency This article will look at why remediation projects are needed the traits of successful programs and what you need to do to ensure success in your remediation e...
AbstractMixedmode chromatography MMC is a fast growing area in recent years thanks to the new generation of mixedmode stationary phases and better understanding of multimode interactions MMC has superior applications in the separation of compounds that are not retained or not well resolved by typical reversedphase LC methods especially for polar and ch
AbstractThis case study has been conducted to establish the fact that Denosumab can be used as an adjuvant therapy by which to avoid or reduce the risks and morbidity of surgical treatment in patients with spinal GCTs extending into the nearby tissues considering the adequate duration safety and lack of adverse events of this treatment even though further
Researchers at the University of Leeds have come up with a technology that could help the pharmaceutical industry in controlling crystal formation during the process of drug developmentPharmaceuticals often come in the crystalline forms and undetected fluctuations in the system can alter the crystal structure which is not desired by the pharmaceutical manufacturers...
SummaryRapid and consistent invivo drug dissolution is critical for drug absorption Invitro dissolutions tests are used to predict invivo disintegration and dissolution properties of drug products The invitro disintegration and dissolution times of tablets and capsules can vary significantly based on their composition and processing
Approximately million people worldwide are living with a rare disease and about half of those affected by rare diseases are children
Although less well known than other drug development phases human factors engineering HFE is critical to meeting regulatory expectations for drugdevic...
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Many advanced largescale AI initiatives still need to be proved successful in Pharma
Singapore has had a multidecade longterm vision for building a worldclass biomedical cluster